European product
CE marking
MDR certification
Backed by clinical trials
Private label available
VeTVISC 3.0 %
3.0% high-molecular-weight hyaluronic acid viscoelastic solution.
Maximum maintenance of anterior chamber space.
- Concentration
- 3.0%
- Presentation (format)
- 1.2 mL prefilled syringe + injection cannula
- Certification
- Veterinary health material and equipment product
- Recommended needle
- 23G
- Shelf life
- 2 years
- Technology
- Linear sodium hyaluronate hydrogel.
Buen perfil de seguridad
Advantages
- Low endotoxin content.
- No refrigeration required.
- HA obtained through biofermentation.
Indications
Indicated as an adjunct during surgical procedures involving the anterior chamber of the eye, particularly cataract surgery, including lens extraction and intraocular lens insertion.
Properties
- Acts as an adjunct in ophthalmic surgery.
- Maintains the depth and integrity of the anterior chamber of the eye, facilitating surgery.
- Facilitates insertion of the intraocular lens.
- Provides excellent visibility of the surgical field.
Directions for use
For administration only by healthcare professionals specialising in ophthalmology, in accordance with all rules governing aseptic procedure and injection technique to ensure treatment safety and efficacy.
Technology
Linear sodium hyaluronate hydrogel.
- Low endotoxin content.
- No refrigeration required.
- HA obtained through biofermentation.
